The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
This is the second US FDA GMP inspection of this facility within one year
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Subscribe To Our Newsletter & Stay Updated
